MODERATOR
:
SPEAKER
(S):
Sandra Ramirez-Arcos, PhD, MSc, Development Scientist and Adjunct Professor, Canadian Blood Services
Canadian experience with prevention of bacterial contamination in platelet concentrates
Elisabeth Maurer-Spurej, PhD, Scientist, Canadian Blood Services, LightIntegra Technology
Technologies for Bacterial Detection of Platelet Concentrates
Stephen Wagner, PhD, Interim Head, Blood Components Department, American Red Cross
Bacterial Inactivation in Platelet Components
Description
Bacterial contamination of platelet components is one of the most common causes of transfusion-related death in North America. Where are we in the process of addressing this risk factor since the introduction of the AABB Standard to detect and limit bacterial contamination in 2004? This session will give an up-to-date overview of preventive measures, technologies to detect, reduce and/or inactivate bacteria and their effectiveness.
-
Discuss different strategies of pathogen inactivation and their effect on platelet concentrates.
-
Discuss the usefulness of bacteria detection technologies as quality control versus point-of-care tests and their success rates in preventing the transfusion of contaminated units.
-
Evaluate established and emerging methods to prevent bacterial contamination of platelet concentrates.
CE Category | CE Value |
---|
California Clinical Laboratory Personnel |
1.5 |
California Nurse |
1.8 |
Florida Laboratory Personnel |
1.8 |
General Attendee |
1.5 |
Physician |
1.5 |
Please note: Continuing education (CE) credit is available for online offerings only. Individuals that purchase CD-ROMs will not receive CE credit for the programs they view.